Product Information
RIFAMPIN 150 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.8035 per EA under NDC 60687057521. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
American Health PackagingNDC
60687057521
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034FDA Approved
8/21/2013
TE Code
AB
On Market Since
3/5/2021
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 150 MG CAPSULE has been published 277 times since May 5, 2021, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8035 per EA |
|---|---|
| All-time high | $1.3166 (Jan 10, 2024) |
| All-time low | $0.5653 (Nov 20, 2024) |
| 52-week high | $0.8035 |
| 52-week low | $0.5959 |
| Median price | $0.7691 |
| Average price | $0.7840 |
| Largest weekly change | +66.2% (Dec 20, 2023) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rifampin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIFAMPIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 150 MG CAPSULE, manufactured by American Health Packaging, is $0.8035 per EA (NDC 60687057521), effective Aug 19, 2026.
How has the price of RIFAMPIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 150 MG CAPSULE has declined 15.0%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 150 MG CAPSULE?
Since May 5, 2021, the NADAC for RIFAMPIN 150 MG CAPSULE has ranged from a low of $0.5653 (Nov 20, 2024) to a high of $1.3166 (Jan 10, 2024), with a median of $0.7691 per EA.
Are there cheaper alternatives to RIFAMPIN 150 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of RIFAMPIN 150 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RIFAMPIN 150 MG CAPSULE?
RIFAMPIN 150 MG CAPSULE (NDC 60687057521) is labeled by American Health Packaging, and CMS classifies it as a generic product.